日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of CFTR Modulator Concentrations on Clinical Response in Cystic Fibrosis

CFTR调节剂浓度对囊性纤维化临床反应的影响

Chalamalla, Ashritha R; Baker, Elizabeth; Ryan, Kevin J; Dowell, Alexander; Natt, Jennifer R; Zemanick, Edith T; Konstan, Michael W; Mayer-Hamblett, Nicole; Acosta, Edward P; Guimbellot, Jennifer S

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study

快速推广应用后评估囊性纤维化调节剂疗法的长期疗效:一项双重方法研究

Miranda Afonso, Pedro; Zhou, Grace C; Su, Weiji; Burgel, Pierre-Régis; Cromwell, Elizabeth; Goss, Christopher H; Keogh, Ruth H; Liou, Theodore G; Marshall, Bruce C; Mayer-Hamblett, Nicole; Morgan, Wayne J; Ostrenga, Joshua S; Pasta, David J; Schechter, Michael S; Stanojevic, Sanja; Wainwright, Claire E; Szczesniak, Rhonda D; Andrinopoulou, Eleni-Rosalina

Culture and Adaptation of Pseudomonas aeruginosa During Early Infection in Children With Cystic Fibrosis

囊性纤维化患儿早期感染期间铜绿假单胞菌的培养和适应

Mitra, Sumitra D; Soneji, Maulin; Axline, Christopher M R; Hayden, Hillary S; Radey, Matthew C; Forsberg, Cara M; Ozer, Egon A; Wolter, Daniel J; Pope, Christopher E; Burns, Jane; Hoffman, Lucas R; Mayer-Hamblett, Nicole; Singh, Pradeep; Hauser, Alan R

Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials

最大限度提高治疗成功率:按顺序参与囊性纤维化核酸疗法试验

Mayer-Hamblett, Nicole; Kerper, Natanya R; Clancy, John P; Davies, Jane C; Taylor-Cousar, Jennifer L; Donaldson, Scott H; Bell, Scott C; Jain, Raksha; Simmonds, Nicholas J; Mall, Marcus A; Goss, Christopher H; Rayment, Jonathan H; Setiawan, Linda; Pilewski, Joseph M

Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry data

阿奇霉素对年轻囊性纤维化患者的影响:一项利用注册数据模拟已发表的随机对照试验的方案

Granger, Emily; Todd, Jonathan; Charman, Susan Christine; Cromwell, Elizabeth; Davies, Gwyneth; Frost, Freddy; Gifford, Alex; Huang, Bin; Hamblett, Nicole Mayer; Naehrlich, Lutz; Ostrenga, Josh; Stanojevic, Sanja; Szczesniak, Rhonda; Keogh, Ruth

Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis

囊性纤维化患者中CFTR调节剂诱导的汗液氯化物浓度的异质性

Zemanick, E T; Emerman, I; McCreary, M; Mayer-Hamblett, N; Warden, M N; Odem-Davis, K; VanDevanter, D R; Ren, C L; Young, J; Konstan, M W

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

停用高渗盐水或重组人脱氧核糖核酸酶对接受依来卡托/替扎卡托/伊伐卡托治疗的囊性纤维化患者黏液纤毛清除功能的影响:SIMPLIFY-MCC 研究

Donaldson, Scott H; Corcoran, Timothy E; Pilewski, Joseph M; Laube, Beth L; Mogayzel, Peter; Ceppe, Agathe; Wu, Jihong; Zeman, Kirby; Rowe, Steven M; Nichols, David P; Gifford, Alex H; Bennett, William D; Mayer-Hamblett, Nicole

Assessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor

评估在服用Elexacaftor/Tezacaftor/Ivacaftor后1秒用力呼气容积降低的患者中停用高渗盐水的安全性

Nichols, David; Gifford, Alex; Russell, Renee; Odem-Davis, Katherine; Young, Julia; Amaro-Galvez, Rodolfo; Billings, Joanne; Mukadam, Zubin; Mayer-Hamblett, Nicole

Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis

囊性纤维化患者在接受 Elexacaftor-Tezacaftor-Ivacaftor 治疗后停用高渗盐水和 Dornase Alfa 的影响

Mayer-Hamblett, Nicole; Gifford, Alex H; Kloster, Margaret; Russell, Renee; Braun, Andrew T; Gibson, Ronald L; Hoppe, Jordana E; Jain, Raksha; Linnemann, Rachel W; Liou, Theodore G; Lysinger, Jerimiah; Milla, Carlos; Riekert, Kristin A; Sawicki, Gregory S; Young, Julia; Nichols, David

University Students as Change Agents for Health and Sustainability: A Pilot Study on the Effects of a Teaching Kitchen-Based Planetary Health Diet Curriculum

大学生作为健康和可持续发展的变革推动者:一项关于以教学厨房为基础的地球健康饮食课程效果的试点研究

Rosenau, Nicola; Neumann, Uwe; Hamblett, Stacey; Ellrott, Thomas